Evaluation of head and neck cancer with 18F-FDG pet: A comparison with conventional methods

European Journal of Nuclear Medicine

Volumn 28, Issue 7, 2001, Pages 816-821

  Kresnik, E ^a   Mikosch, P ^a   Gallowitsch, H J ^a   Kogler, D ^a   Wieser, S ^a   Heinisch, M ^a   Unterweger, O ^a   Raunik, W ^a   Kumnig, G ^a   Gomez, I ^a   Grunbacher G ^a   Lind, P ^a  

^a GENERAL HOSPITAL KLAGENFURT   (Austria)

Author keywords

18F FDG PET; Conventional imaging methods; Head and neck cancer; Restaging; Staging

Indexed keywords

ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; ENDOSCOPY; FEMALE; HEAD AND NECK CANCER; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY; RADIOGRAPHY; TUMOR BIOPSY;

FEMALE; FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OTORHINOLARYNGOLOGIC NEOPLASMS; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0034926067     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590100554     Document Type: Article

References (21)

1. Early detection in the upper aerodigestive tract, part I
2. Diagnostic evaluation of squamous cell carcinoma metastatic to cervical lymph nodes from an unknown head and neck primary site
3. Diagnostic evaluation of malignant head and neck cancer by F-18-FDG PET compared to CT/MRI
4. Evaluation of chemotherapy response in patients with advanced head and neck cancer using [F-18] fluorodeoxyglucose positron emission tomography
5. PET scanning in head and neck oncology: A review
6. MRI imaging, part I. Initial evaluation
7. Magnetic resonance tomography and computerized tomography in tumor staging of mouth and oropharyngeal cancer
8. Cervical metastases from unknown primaries: Radiotherapeutic management and appearance of subsequent primaries
9. Uses and limitations of FDG positron emission tomography in patients with head and neck cancer
10. Positron emission tomography in the evaluation of the NO neck
11. The role of positron emission tomography in occult primary head and neck cancers
12. Fluorine-18 deoxyglucose and false-positive results: A major problem in the diagnostics of oncological patients
13. Dual time point fluorine-18 fluorodeoxyglucose positron emission tomography: A potential method to differentiate malignancy from inflammation and normal tissue in the head and neck
14. Detection of cervical metastasis: A meta-analysis comparing computed tomography with physical examination
15. Comparison of fluorine-18-fluorodeoxyglucose, PET, MRI and endoscopy for staging head and neck squamous cell carcinomas
16. The role of FDG-PET in preoperative assessment of N-staging in head and neck cancer
17. The detection of local recurrent head and neck cancer with fluorine-18 fluorodeoxyglucose dual-head positron emission tomography
18. Positron emission tomography: A new, precise imaging modality for detection of primary head and neck tumors and assessment of cervical adenopathy
19. Recurrence of head and neck cancer after surgery or irradiation: Prospective comparison of 2-deoxy-2[F-18]-fluoro-D-glucose PET and MRI imaging diagnoses
20. CT and MR appearance of recurrent malignant head and neck neoplasm after resection and flap reconstruction
21. Detection of lymph node metastases of squamous-cell cancer of the head and neck with FDG-18 PET and MRI